JACKSONVILLE, Fla.--(Business Wire)--
NovaBone Products, LLC (NBP) has released a new form of the
synthetic bone graft, NovaBone Putty(R) (bone graft substitute).
"Surgeons now have a synthetic that handles more easily," said Arthur
Wotiz, CEO of NovaBone Products. "NovaBone Bioactive Synthetic Graft
is the only bone graft substitute that has been proven to signal,
recruit, proliferate and differentiate osteoblasts. The events
culminate in the formation of strong bone fast," continued Wotiz. No
other synthetic bone graft material performs like NovaBone.
NovaBone(R), a calcium-phosphate silicate, goes through an ionic
dissolution process that signals the body to send more precursors to
the wound site earlier and forms an apatite surface layer that acts as
a framework for osteoblast attachment and new bone formation. This
results in an increase in osteoblast function over the first few
weeks. The FDA has approved the term osteostimulation to describe Nova
Bone's capability.
"I have used NovaBone particulate for several hundred spine fusion
cases with excellent results," said Craig Chebuhar, MD, Director of
the Pinnacle Spine Center in Marietta, GA. "The putty form utilizes
the same technology platform - it is ready to use right out of the
package, handles great, and doesn't migrate - making it the easiest to
use bone graft substitute on the market. The combination of scientific
evidence and user friendliness makes this product an excellent
grafting option for my patients both as a stand-alone product or as
part of a composite bone graft with allograft or autograft," said
Chebuhar
NovaBone is the only synthetic that is osteostimulative, directly
increasing the proliferation and activity of osteoblasts, the cells
responsible for new bone growth. This results in more extensive early
bone formation than seen for other synthetic graft materials when
evaluated during in vivo testing.
NovaBone Products, LLC is the manufacturer of NovaBone and is
headquartered in Jacksonville, FL with laboratory operations in
Alachua, FL, a sales office in Shanghai and distributors worldwide.
The company is dedicated to delivering best in class synthetic bone
graft substitutes to the surgical community, with unprecedented focus
on service and commitment to its user base.
NBP is in the process of establishing a distribution network in
the USA. The company's focus is to select independent distributors and
manufacturers representatives that already have good lines of
orthopedic hardware and provide them with a complete line of
osteobiologics. "We have been extremely pleased with the eager
response we have gotten already from distributors across the country,"
said Art Wotiz, President of NBP. "It seems clear that we are
satisfying an important need in the market place", he added.
NovaBone Products, LLC, Jacksonville
Dennis McBride, Vice President, Product Development,
908-881-0081 (C), 908-287-2284 (O)
dmcbride@novabone.com
Copyright Business Wire 2008
